Noradrenergic mechanisms in the prefrontal cortex

Journal of Psychopharmacology

Volumn 11, Issue 2, 1997, Pages 163-168

  Nutt, D J ^a   Lalies, M D ^a   Lione, L A ^a   Hudson, A L ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

2 adrenoceptors; Brain microdialysis; Imidazoline receptors; Noradrenaline

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; CLONIDINE; CLOZAPINE; DESIPRAMINE; IDAZOXAN; IMIDAZOLINE RECEPTOR; MIANSERIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NORADRENALIN; RISPERIDONE; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

BRAIN FUNCTION; DRUG MECHANISM; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MICRODIALYSIS; NEUROCHEMISTRY; NORADRENALIN BRAIN LEVEL; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; STRESS;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BRAIN MAPPING; HUMANS; NOREPINEPHRINE; PREFRONTAL CORTEX; RECEPTORS, DRUG; SYNAPTIC TRANSMISSION;

EID: 0030904229     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119701100209     Document Type: Review

References (35)

1. 2,-imidazoline sites. J. Pharmac Exp Ther 272: 681-688
2. Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M (1993) Psychobiological mechanisms of post-traumatic stress disorder. Arch Gen Psychiat 50: 294-305
3. Dennis T, L'Heureux R, Carter C, Scatton B (1987) Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release. J Pharmac Exp Ther 241: 642-649
4. 3H]rauwolscine. Brain Res 566: 13-20
5. 2 subtypes. Fund Clin Pharmacol, 6, (Suppl. 1) P18
6. Freedman J E, Aghajanian G K (1984) Idazoxan (RX 781094) selectively antagonizes a2-adrenoceptors on rat central neurons. Eur J Pharmac 105: 265-272
7. 14C]2-deoxyglucose and microdialysis studies. Neuropharmacology 34: 605-613
8. García-Sevilla J A, Escriba P V, Sastre M, Walzer C, Busquets X, Jaquet G, Reis D J, Guimon J (1996) Immunodetection and quantification of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Arch Gen Psychiat 53: 803-810
9. Gartside S E, Umbers V, Hajos M, Sharp T (1995) Interactions between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmac 115: 1064-1070
10. Ghika J, Tennis M, Hoffman B A, Schoenfeld D, Growden J (1991) Idazoxan treatment in progressive supranuclear palsy. Neurology 41: 986-991
11. Glue P, Costello M J, Pert A, Mele A, Nutt D J (1990) Regional neurotransmitter responses after acute and chronic electroconvulsive shock. Psychopharmacology 100: 60-65
12. Green A R (1990) The effects of antidepressant drugs on noradrenergic receptor mechanisms in the central nervous system. In Heal D J, Marsden C A (eds), The pharmacology of noradrenaline in the central nervous system. Oxford University Press, Oxford, pp. 316-348
13. Holets V R (1990) The anatomy and function of noradrenaline in the mammalian brain. In Heal, D J, Marsden C A (eds), The pharmacology of noradrenaline in the central nervous system. Oxford University Press, Oxford, pp. 1-40
14. 2-sites). Br J Pharmac 112: 320P
15. 3H]2-(-2-benzofuranyl)-2-imidazoline in rat brain. Br J Pharmac 116: 338P
16. 2 receptors. Eur J Pharmac 304: 221-229
17. Litman R E, Su T P, Potter W Z, Hong W W, Pickar D (1996) Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Br J Psychiat 168: 571-579
18. L'Heureux R, Dennis T, Curet O, Scatton B (1986) Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: effects of drugs affecting noradrenergic transmission. J Neurochem 46: 1794-1801
19. 3H]-RS-45041-190, a potent and selective radioligand for I2 imidazoline receptors. Br J Pharmac 98: 1729-1736
20. Mallard N J, Hudson A L, Nutt D J (1992) Characterisation and autoradiographic localization of non adrenoceptor binding sites in the rat brain. Br J Pharmac 106: 1019-1027
21. 2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics. J Psychopharmac 8(4): 193-195
22. Nutt D J, Glue P (1992) The neurobiology of ECT: animal studies. In: Coffey C E (ed.), ECT: from research to clinical practice. American Psychiatric Association, Washington DC, pp. 241-265
23. Nutt D J, Holman R B, Thomas D N (1992) Noradrenergic mechanisms in anxiolytic and antidepressant drug action. In Elliott MJ (ed.), Experimental approaches to anxiety and depression. John Wiley, Chichester, pp. 101-106
24. Nutt D J, French N, Handley S, Hudson A, Husbands S, Jackson H C, Jordan S, Lalies M D, Lewis J W, Lione L, Mallard N, Pratt J (1995) Functional studies of specific imidazoline-2 receptor ligands. In Reis DJ, Bousquet P, Parini A (eds), The imidazoline receptor: pharmacology, functions, ligands and relevance to biology and medicine. New York Academy of Sciences, New York, pp. 125-139
25. Ordway G A, Widdowson P S, Smith K S, Halaris A E (1994) Agonist binding to a2-adrenoceptors is elevated in the locus coeruleus from suicide victims. J Neurochem 63: 617-624
26. Parini A, Moudanos C G, Pizzanat N, Lanier S M (1996) The elusive family of imidazoline binding sites. Trends Pharmac Sci 17: 13-16
27. Pickar D, Owen D (1992) Clinical and biological response to clozapine in patients with schizophrenia: crossover comparison with fluphenazine. Arch Gen Psychiat 49: 345-353
28. 1 is elevated in mood disorders. Fund Clin Pharmac 6 (Suppl. 1): III 19
29. Reynolds G P, Boulton R M, Pearson S J, Hudson A L, Nutt D J (1996) Imidazoline binding sites in Huntington's and Parkinson's disease putamen. Eur J Pharmac 301: R19-R21
30. Routledge C, Marsden C A (1987) Comparison of the effects of selected drugs on the release of hypothalamic adrenaline and noradrenaline measured in vivo. Brain Res 426: 103-111
31. Stanford C, Nutt D J (1982) Comparison of the effects of repeated electroconvulsive shock on alpha2- and beta-receptors in different regions of rat brain. Neuroscience 7: 1753-1757
32. Stanford C, Nutt D J, Cowen P J (1983) Comparison of the effects of chronic desmethyl imipramine administration on alpha2 and beta adrenoceptors in different regions of rat brain. Neuroscience 8: 161-164
33. Thomas D N, Holman R B (1991) A microdialysis study of the regulation of endogenous noradrenaline release in the rat hippocampus. J Neurochem 56: 1741-1746
34. Thomas D N, Nutt D J, Holman R B (1992) Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex. Br J Pharmac 106: 430-434
35. Thomas D N, Nutt D J, Holman R B (1994) Regionally specific changes in extracellular noradrenaline following chronic idazoxan as revealed by in vivo microdialysis. Eur J Pharmac 261 (1-2): 53-57